Monday, May 06, 2019 3:25:16 PM
I would like to thank everyone for all the hard work with all the statistics that have been presented to this message board. I can't name all of you ! They have benefited me more than I can express.
We things start to move there will not be time for simple posts.
But now - I'm threw with the stats ...... Carry on but
I'm just sitting waiting and have a much simpler view.
CURE?
Well there are many ways to look at that word/process .
A nice simple 4 to 5 years of progressive free tumor sounds great.
And it is ....
5 years ? Well that's a long time --- If I was a younger man of lets say 40 years old and went through the process of DCVAX - then 4,5,6 years later I had a recurrence of a tumor, why not go thorough the process again. That is a cure in my book
For another 4,5,6,7,8,years of progressive free years??? And by then there can be a news / better formula for DCVAX.
Would I be able to go through the side effects again? A little humor because we all know that there aren't any side effects.
Yes - I have no problem calling it a Cure to my Group of People that I brought into this group.
Don't Make Me Leak --- Until we Get our Final Results
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM